Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current therapy of bladder cancer.

W F Whitmore1

  • 1Urology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association
|September 1, 1990
PubMed
Summary

Bladder cancer treatment varies by tumor type. Superficial cancers need intravesical therapies, while invasive cancers benefit from systemic chemotherapy, improving survival and bladder preservation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemotherapy and trace element levels in blood and tissue of rats implanted with prostate tumor cells.

Biological trace element research·2013
Same author

Recent contributions to the theory of random functions.

Science (New York, N.Y.)·2010
Same author

Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer.

The Journal of urology·1997
Same author

Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1995
Same author

Distinguishing prognostic and treatment-predictive information for localized prostate cancer.

Urology·1995
Same author

Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostatic cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1995

Area of Science:

  • Oncology
  • Urology

Background:

  • Bladder cancer presents as a heterogeneous spectrum of neoplasms.
  • Treatment strategies differ based on tumor stage, with superficial tumors facing recurrence and muscle-infiltrating tumors risking metastasis.

Purpose of the Study:

  • To review current treatment modalities for bladder cancer.
  • To highlight advancements in systemic chemotherapy for advanced disease.
  • To emphasize the need for tailored therapy based on tumor heterogeneity.

Main Methods:

  • Review of existing literature on bladder cancer treatments.
  • Analysis of treatment outcomes for superficial and muscle-infiltrating bladder cancers.
  • Discussion of evolving systemic chemotherapy regimens and pilot studies.

Main Results:

  • Local control is achievable with appropriate treatment selection.
  • Intravesical therapies are effective for superficial neoplasms.
  • Systemic chemotherapy has led to significant advancements, including combination regimens with complete responses.

Conclusions:

  • Tumor heterogeneity necessitates precise characterization for optimal, individualized bladder cancer therapy.
  • Ongoing research focuses on improving survival and bladder preservation through combined treatment approaches.
  • A move towards more rational, less empirical treatment selection is crucial given expanding therapeutic options.

Related Experiment Videos